Monte Rosa Therapeutics, Inc. (GLUE) Earnings
|
Expand Research on GLUE
| Next EPS Date | 11/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +100.0% | Revenue Growth Rate | +11.8% |
| Average % Move 1-Wk after EPS | +0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.36 | N/A | N/A | $14.28M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | $0.00 | -$0.38 | +$0.38 | $8.97M | $12.91M | N/A |  | | Details | |
| 5/7/26 | Q126 | $0.00 | -$0.36 | +$0.36 | $4.21M | $13.57M | N/A | | | Details | |
| 3/17/26 | Q425 | $0.00 | -$0.33 | +$0.33 | $2.78M | $15.55M | N/A | | | Details | |
| 3/16/26 |
Q425 | N/A | -$0.33 | N/A | N/A | $15.55M | N/A | N/A | N/A | ||
| 3/12/26 |
Q425 | N/A | -$0.33 | N/A | N/A | $15.55M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | $0.00 | -$0.36 | +$0.36 | $12.77M | $7.77M | N/A | | | Details | |
| 8/7/25 | Q225 | $0.00 | -$0.38 | +$0.38 | $23.19M | $6.33M | N/A | | | Details |
